Major clinical application of adipose derived stem cells
Sanjay Gottipamula, Kumar Chokalingam
Affiliation
Sri Research for Tissue Engineering Pvt. Ltd, Sri Shankara Research Centre, Rangadore Memorial Hospital, Bangalore, India.
Corresponding Author
Sridhar, K.N. M.B.B.S, L.R.C.P (London), M.R.C.S (England), F.R.C.S. (Ireland, Edinburg, England, Canada), F.R.C.P.S. (Glasgow), Sri Research for Tissue Engineering Pvt. Ltd, Sri Shankara Research Centre, Rangadore Memorial Hospital, Bangalore, India, Tel: +91-080-41076759; Email: knsridhar@sr-te.com
Citation
Sridhar K.N., et al. Major Clinical Application of Adipose-Derived Stromal Cells. (2018) J Stem Cell Regen Biol 4(1): 4- 19.
Copy rights
© 2018 Sridhar K.N. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License
Keywords
Abstract
In recent years, Adipose-Derived Stromal Cells (ADSCs) have emerged as a potent source of therapeutic cells for the treatment of various clinical indications. This review focusses on ADSCs as a product and the current clinical trial landscape of ADSCs. In-depth emphasis has been given for the clinical and conceptual framework of ADSCs to treat ischemic based indications such as Inflammatory Bowel Dieseases, Cerebrovascular Diseases, Chronic Obstructive Pulmonary Disease, sclerosis based indications such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Systemic Sclerosis, Crohn based Fistula, and Osteoarthritis.